Regencell Bioscience Holdings Stock Price Prediction
| RGC Stock | USD 5.10 0.60 10.53% |
Oversold Vs Overbought
35
Oversold | Overbought |
Regencell Bioscience stock price prediction is an act of determining the future value of Regencell Bioscience shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Regencell Bioscience's future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Regencell Bioscience and does not consider all of the tangible or intangible factors available from Regencell Bioscience's fundamental data. We analyze noise-free headlines and recent hype associated with Regencell Bioscience Holdings, which may create opportunities for some arbitrage if properly timed.
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Regencell Bioscience based on different types of headlines from major news networks to social media. The Regencell stock price prediction module provides an analysis of price elasticity to changes in media outlook on Regencell Bioscience over a specific investment horizon. Using Regencell Bioscience hype-based prediction, you can estimate the value of Regencell Bioscience Holdings from the perspective of Regencell Bioscience response to recently generated media hype and the effects of current headlines on its competitors.
This module is based on analyzing investor sentiment around taking a position in Regencell Bioscience. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Regencell Bioscience to buy its stock at a price that has no basis in reality. In that case, they are not buying Regencell because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Regencell Bioscience after-hype prediction price | USD 5.68 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Regencell |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Regencell Bioscience's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Regencell Bioscience After-Hype Price Prediction Density Analysis
As far as predicting the price of Regencell Bioscience at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Regencell Bioscience or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Regencell Bioscience, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Regencell Bioscience Estimiated After-Hype Price Volatility
In the context of predicting Regencell Bioscience's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Regencell Bioscience's historical news coverage. Regencell Bioscience's after-hype downside and upside margins for the prediction period are 0.28 and 13.84, respectively. We have considered Regencell Bioscience's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Regencell Bioscience is very risky at this time. Analysis and calculation of next after-hype price of Regencell Bioscience is based on 3 months time horizon.
Regencell Bioscience Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Regencell Bioscience is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Regencell Bioscience backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Regencell Bioscience, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.28 | 8.16 | 0.02 | 0.04 | 5 Events / Month | 8 Events / Month | In about 5 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
5.10 | 5.68 | 0.35 |
|
Regencell Bioscience Hype Timeline
On the 24th of April Regencell Bioscience is traded for 5.10. The entity has historical hype elasticity of -0.02, and average elasticity to hype of competition of 0.04. Regencell is forecasted to decline in value after the next headline, with the price expected to drop to 5.68. The average volatility of media hype impact on the company price is over 100%. The price depreciation on the next news is expected to be -0.35%, whereas the daily expected return is at this time at -0.28%. The volatility of related hype on Regencell Bioscience is about 6427.88%, with the expected price after the next announcement by competition of 5.14. About 89.0% of the company outstanding shares are owned by corporate insiders. The book value of Regencell Bioscience was at this time reported as 0.92. The company has Price/Earnings To Growth (PEG) ratio of 2.15. Regencell Bioscience recorded a loss per share of 0.45. The entity last dividend was issued on the 1st of December 2017. Considering the 90-day investment horizon the next forecasted press release will be in about 5 days. Check out Regencell Bioscience Basic Forecasting Models to cross-verify your projections.Regencell Bioscience Related Hype Analysis
Having access to credible news sources related to Regencell Bioscience's direct competition is more important than ever and may enhance your ability to predict Regencell Bioscience's future price movements. Getting to know how Regencell Bioscience's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Regencell Bioscience may potentially react to the hype associated with one of its peers.
Regencell Bioscience Additional Predictive Modules
Most predictive techniques to examine Regencell price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Regencell using various technical indicators. When you analyze Regencell charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Regencell Bioscience Predictive Indicators
The successful prediction of Regencell Bioscience stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Regencell Bioscience Holdings, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Regencell Bioscience based on analysis of Regencell Bioscience hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Regencell Bioscience's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Regencell Bioscience's related companies. | 2016 | 2017 | 2023 | 2024 (projected) | Dividend Yield | 0.0844 | 0.0846 | 0.0973 | 0.0924 | Price To Sales Ratio | 0.51 | 0.52 | 0.47 | 0.36 |
Story Coverage note for Regencell Bioscience
The number of cover stories for Regencell Bioscience depends on current market conditions and Regencell Bioscience's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Regencell Bioscience is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Regencell Bioscience's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
View All Premium Stories
Regencell Bioscience Short Properties
Regencell Bioscience's future price predictability will typically decrease when Regencell Bioscience's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Regencell Bioscience Holdings often depends not only on the future outlook of the potential Regencell Bioscience's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Regencell Bioscience's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 13 M | |
| Cash And Short Term Investments | 11.6 M |
Check out Regencell Bioscience Basic Forecasting Models to cross-verify your projections. Note that the Regencell Bioscience information on this page should be used as a complementary analysis to other Regencell Bioscience's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Complementary Tools for Regencell Stock analysis
When running Regencell Bioscience's price analysis, check to measure Regencell Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Regencell Bioscience is operating at the current time. Most of Regencell Bioscience's value examination focuses on studying past and present price action to predict the probability of Regencell Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Regencell Bioscience's price. Additionally, you may evaluate how the addition of Regencell Bioscience to your portfolios can decrease your overall portfolio volatility.
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |
Is Regencell Bioscience's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Regencell Bioscience. If investors know Regencell will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Regencell Bioscience listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.45) | Return On Assets (0.26) | Return On Equity (0.42) |
The market value of Regencell Bioscience is measured differently than its book value, which is the value of Regencell that is recorded on the company's balance sheet. Investors also form their own opinion of Regencell Bioscience's value that differs from its market value or its book value, called intrinsic value, which is Regencell Bioscience's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Regencell Bioscience's market value can be influenced by many factors that don't directly affect Regencell Bioscience's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Regencell Bioscience's value and its price as these two are different measures arrived at by different means. Investors typically determine if Regencell Bioscience is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Regencell Bioscience's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.